Skip to main content
This website uses cookies. By continuing to use this website you are agreeing to our use of cookies as described in our privacy policy.
Sylvie  Bourdeau

Sylvie Bourdeau

Partner Fasken
Assessing the risks associated with a business transaction and the solutions put forward to properly allocate, control or mitigate them is a key element of its success.
Jurisdiction Quebec, 1988
Language(s) French, English
Office(s) Montreal
Contact

Sylvie Bourdeau specializes in business and mergers and acquisition law.  Over the years she has been involved in numerous mandates involving the financial products and services and life sciences/pharmaceuticals industries.

 

In addition to the numerous mergers and acquisitions and private financings mandates in which she has been involved in her practice, Sylvie’s also represented many clients in matters involving the drafting of complex commercial agreements, including  for joint ventures, franchises, collaboration agreements, outsourcing of services, licensing, distribution, manufacturing and limited partnerships.

 

Sylvie has acquired extensive expertise in the regulations governing financial institutions (insurers, trust companies and deposit institutions) and advises many of them on a regular basis with respect to the regulations applicable in Canada and Québec. She counsels clients in connection with the creation of new financial institutions, reinsurance, rules governing investments and capital management, compliance, development of new products, consumer protection and the contracts and operations related to their activities. Her experience in the regulation of financial institutions, combined with her expertise in business law, make her a trusted resource for the “Fin Tech” industry in general. Sylvie also assists clients in their dealings with the competent regulatory authorities.

 

Sylvie is co-leader of the national Life Sciences Practice Group and advises a number of clients in the life sciences and pharmaceutical industries on commercial operations of all kinds and on issues related to the legislation of the health sector applicable in Québec.

2015 Named "Canadian Financial & Transactional Attorney of the Year" by the LMG Life Sciences Awards (2015)
Date

Education

  • LLB University of Montréal

Community involvement

  • Active member of the Comité Femmes au CA, Association of Québec Women in Finance
  • Member of the Board of Directors and Chair of the Ethics Committee of the Commission administrative des régimes de retraite et d'assurances (CARRA) (2009 to 2015)
  • Member of the Board of Directors of Valeo Corporation Inc.
  • Member of the Board of Directors and Chair of the Ethics Committee, YWCA Montreal
  • Member of the Board of Directors of Leucan (2008 to 2010)

Memberships & Affiliations

  • Member, Canadian Bar Association
  • Member, Québec Bar
  • Member, Bar of Montréal
  • Member, Réseau Capital
  • Member, Association of Québec Women in Finance
Article The Canadian Insurance M&A Environment Asian-Mena Counsel M&A Special Report
Newsletter Life Line Life Sciences Newsletter
The Framework Essentials of Fintech in Canada (Les essentiels de l’encadrement des FINTECH au Canada) location location Montreal Hotel Omni Mont-Royal
Fintechs: What are the legal issues?

    Subscribe

    Receive email updates from our team

    Subscribe